REPORT ID 6269

EMEA (Europe, Middle East and Africa) Rotavirus Vaccine Market Report 2017

Publish Date
25-Dec-17
Pages
104
Format
Electronic (PDF)

In this report, the EMEA Rotavirus Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Rotavirus Vaccine for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Rotavirus Vaccine market competition by top manufacturers/players, with Rotavirus Vaccine sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Merck
    GSK
    Sanofi
    ...

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    By Type
        Oral
        Others
    By Type 2
        Live Attenuated Vaccine
        Inactivated Vaccine

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Clinics
    Public Services
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Rotavirus Vaccine Market Report 2017
1 Rotavirus Vaccine Overview
    1.1 Product Overview and Scope of Rotavirus Vaccine
    1.2 Classification of Rotavirus Vaccine
        1.2.1 EMEA Rotavirus Vaccine Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Rotavirus Vaccine Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Oral
        1.2.4 Others
    1.3 EMEA Rotavirus Vaccine Market by Application/End Users
        1.3.1 EMEA Rotavirus Vaccine Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Hospital
        1.3.3 Clinics
        1.3.4 Public Services
        1.3.5 Others
    1.4 EMEA Rotavirus Vaccine Market by Region
        1.4.1 EMEA Rotavirus Vaccine Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Rotavirus Vaccine (2012-2022)
        1.5.1 EMEA Rotavirus Vaccine Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Rotavirus Vaccine Revenue and Growth Rate (2012-2022)

2 EMEA Rotavirus Vaccine Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Rotavirus Vaccine Market Competition by Players/Manufacturers
        2.1.1 EMEA Rotavirus Vaccine Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Rotavirus Vaccine Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Rotavirus Vaccine Sale Price by Players (2012-2017)
    2.2 EMEA Rotavirus Vaccine (Volume and Value) by Type/Product Category
        2.2.1 EMEA Rotavirus Vaccine Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Rotavirus Vaccine Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Rotavirus Vaccine Sale Price by Type (2012-2017)
    2.3 EMEA Rotavirus Vaccine (Volume) by Application
    2.4 EMEA Rotavirus Vaccine (Volume and Value) by Region
        2.4.1 EMEA Rotavirus Vaccine Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Rotavirus Vaccine Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Rotavirus Vaccine Sales Price by Region (2012-2017)

3 Europe Rotavirus Vaccine (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Rotavirus Vaccine Sales and Value (2012-2017)
        3.1.1 Europe Rotavirus Vaccine Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Rotavirus Vaccine Revenue and Growth Rate (2012-2017)
    3.2 Europe Rotavirus Vaccine Sales and Market Share by Type
    3.3 Europe Rotavirus Vaccine Sales and Market Share by Application
    3.4 Europe Rotavirus Vaccine Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Rotavirus Vaccine Sales Volume by Countries (2012-2017)
        3.4.2 Europe Rotavirus Vaccine Revenue by Countries (2012-2017)
        3.4.3 Germany Rotavirus Vaccine Sales and Growth Rate (2012-2017)
        3.4.4 France Rotavirus Vaccine Sales and Growth Rate (2012-2017)
        3.4.5 UK Rotavirus Vaccine Sales and Growth Rate (2012-2017)
        3.4.6 Russia Rotavirus Vaccine Sales and Growth Rate (2012-2017)
        3.4.7 Italy Rotavirus Vaccine Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Rotavirus Vaccine Sales and Growth Rate (2012-2017)

4 Middle East Rotavirus Vaccine (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Rotavirus Vaccine Sales and Value (2012-2017)
        4.1.1 Middle East Rotavirus Vaccine Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Rotavirus Vaccine Revenue and Growth Rate (2012-2017)
    4.2 Middle East Rotavirus Vaccine Sales and Market Share by Type
    4.3 Middle East Rotavirus Vaccine Sales and Market Share by Application
    4.4 Middle East Rotavirus Vaccine Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Rotavirus Vaccine Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Rotavirus Vaccine Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Rotavirus Vaccine Sales and Growth Rate (2012-2017)
        4.4.4 Israel Rotavirus Vaccine Sales and Growth Rate (2012-2017)
        4.4.5 UAE Rotavirus Vaccine Sales and Growth Rate (2012-2017)
        4.4.6 Iran Rotavirus Vaccine Sales and Growth Rate (2012-2017)

5 Africa Rotavirus Vaccine (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Rotavirus Vaccine Sales and Value (2012-2017)
        5.1.1 Africa Rotavirus Vaccine Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Rotavirus Vaccine Revenue and Growth Rate (2012-2017)
    5.2 Africa Rotavirus Vaccine Sales and Market Share by Type
    5.3 Africa Rotavirus Vaccine Sales and Market Share by Application
    5.4 Africa Rotavirus Vaccine Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Rotavirus Vaccine Sales Volume by Countries (2012-2017)
        5.4.2 Africa Rotavirus Vaccine Revenue by Countries (2012-2017)
        5.4.3 South Africa Rotavirus Vaccine Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Rotavirus Vaccine Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Rotavirus Vaccine Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Rotavirus Vaccine Sales and Growth Rate (2012-2017)

6 EMEA Rotavirus Vaccine Manufacturers/Players Profiles and Sales Data
    6.1 Merck
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Rotavirus Vaccine Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Merck Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 GSK
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Rotavirus Vaccine Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 GSK Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Sanofi
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Rotavirus Vaccine Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Sanofi Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    ...

7 Rotavirus Vaccine Manufacturing Cost Analysis
    7.1 Rotavirus Vaccine Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Rotavirus Vaccine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Rotavirus Vaccine Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Rotavirus Vaccine Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Rotavirus Vaccine Market Forecast (2017-2022)
    11.1 EMEA Rotavirus Vaccine Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Rotavirus Vaccine Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Rotavirus Vaccine Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Rotavirus Vaccine Price and Trend Forecast (2017-2022)
    11.2 EMEA Rotavirus Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Rotavirus Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Rotavirus Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Rotavirus Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Rotavirus Vaccine Sales Forecast by Type (2017-2022)
    11.7 EMEA Rotavirus Vaccine Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer